SUMMARY Polymorphonuclear leucocyte (PMN) function was studied in 7 healthy subjects before and after 5 mg of colchicine taken in divided doses over 24 hours. Mean adherence to nylon fibre colums fell from a pretreatment level of 51 % to 33 -6 % by day 1, remained low (31 -8 %) at day 5, and returned to pretreatment levels only by about day 9. Random motility (agarose plate method) fell from 932 ,um to 688 ,um by day 1, but had returned to normal by day 5 hours. Blood samples were taken into heparinised containers (10 IU heparin/ml) on the morning prior to the first dose and subsequently each morning.
clearly defined. Following the work of McCarty' it is generally accepted that the polymorphonuclear leucocyte (PMN) is the chief cell concerned in the inflammatory response mounted against urate crystals. Most work on colchicine has centred on its effect on this cell. Such studies have generally employed in-vitro systems to test the effect of the drug on various aspects of PMN function. These often involved such high concentrations of the drug as to make the clinical relevance of any findings dubious.2 Because of this we have followed 3 aspects of PMN function in volunteers given colchicine within the dosage range used in acute gout.
SUBJECTS AND METHODS
Healthy male laboratory and medical staff took 5 mg of colchicine orally in divided doses over 24
hours. Blood samples were taken into heparinised containers (10 IU heparin/ml) on the morning prior to the first dose and subsequently each morning.
Cell preparation. Heparinised whole blood was used for the adherence studies. For heated in a water bath at 600C. The agarose solution was allowed to cool to 450C and added to an equal volume of diluted 199 medium containing human serum albumin, penicillin, and streptomycin. Sodium bicarbonate was then added to give the following concentrations: 1 % albumin, 350 mg/ml NaHCO3, 500 units penicillin/ml, 500 ,±g streptomycin/ml. 8-5 ml of this solution was decanted into tissue culture plates (85 x 10 mm; Sterilin Products, Teddington, UK) and allowed to harden by refrigeration at 40C for 30 minutes. Wells were cut 2 mm apart in the agarose film with a 3 mm skin punch biopsy punch (Steifel Laboratories, UK). The chemoattractant used was zymosan-activated pooled human serum prepared by adding 100 ,ul of zymosan suspension (10 mg/ml in saline) to 500 V1 of pooled human serum. 7 V.1 of zymosan-activated serum was placed in one well. One hour later 2-5 x 105 purified PMN was added to the opposite well and the plates incubated in a humidified incubator with 4% CO2 for 21 hours. The cells were then fixed by pouring 100 % methanol on to the plates and leaving for at least 1 hour. Next the agarose gel was peeled off leaving the cells adherent to the plates. After drying, the cells were stained with toluidine blue. Migration distances were measured to the leading cell by an electronic micrometer attached to the microscope stage. Random motility was similarly measured on separate tissue culture plates from which chemotaxins were excluded. All experiments were carried out in quadruplicate.
Phagocytosis was measured by a modification of Lehrer and Cline's method. 6 
